Bill would extend newborn screening programs and boost funding through 2030

What does this do?

HR 4709 renews federal newborn screening programs through 2030 and raises allowed funding, one stream from about $11.9 million to $20.9 million and another from $8 million to $22.25 million per year. It updates the expert advisory committee's public reporting duties, improves post-screening data tracking between states and registries, and makes the Hunter Kelly Research Program mandatory.

Who does it affect?

State health departments, hospitals, medical laboratories, parents of newborns, and rare-disease researchers are affected.

Why does it matter?

Because it reauthorizes and expands existing programs rather than creating new ones, it would mainly result in more consistent funding and better coordination for screening and follow-up care nationwide.

What does it cost, and who pays?

• Funding extended through 2030
• One stream: $11.9M to $20.9M
• Other stream: $8M to $22.25M